Interview with André Bràzay, President, Sandoz Hungary
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Address: Bartók Béla út 43-47 H-1114 Budapest,Hungary
Tel: +36 1 430 28 90
Web: http://www.sandoz.hu/site/hu/index.shtml
The Sandoz Pty Ltd ‘s mission pillars, goals, aspirations, our values match, the international principles of Sandoz.
It is our fundamental duty is to our products, our activities improve our lives. To that end, patent medicines from leaving active gyógyszerösszetevőket, a wide range of biotechnology products developed, manufactured and sold at an affordable price, but meeting the highest standards of quality.
During our activities we have created a value system that gives all our partners, our customers continuously expect the highest standards of serving. The world’s leading generic manufacturer of the task we facilitate access to medical care, and health care systems támogatását.Tesszük all aware of the responsibility which the market maker requires.
The Sandoz social responsibility committed, so seek him, that of our long-term, sustainable, economic, social and environmental aspects.
The company’s philosophy of most of the high quality, global presence and innovation in threes we legtömörebben summarized.
The high quality standards by Sandoz in the ever-increasing customer demands are fully met aims itself.
A global presence provides Sandoz for a uniform, international business, as in other countries experienced positive trends, and immediately at the national market .
The innovation – paradoxically – Sandoznál tradition. Our product range is a continuous expansion of committed ourselves to ensuring that our clients always know the latest products and technologies provide.
The Sandoz Hungaria Ltd. we are committed to earn our unreserved confidence. To this end, the company’s global experience and innovative approach we use the best quality, unique products and services we provide. Our goal is to earn customer trust, and they regarded us as a generic drug manufacturers the most customer-oriented company of.
Sandoz Hungaria Ltd. continuously monitor our clients’ changing needs and strive to creativity and innovative approach to these needs as possible to able to answer.
Therapeutic Areas
Market-leading product portfolio (so-called ‘blockbuster’) and fill gaps in its niche market for both drugs include all major therapeutic areas, in particular:
Antibiotics
Cardiovascular
Central Nervous System
Stomach and digestive tract
Osteoporosis
Dermatology
Allergy
Oncology
Muscle and skeletal
Urology
Top 5 products containing active worldwide
Fentanyl
Omeprazole
Amoxicillin-clavulanate
Metoprolol
Simvastatin
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of Prime Minister…
Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application…
Dr Beata Sperlagh, Deputy Director of the Institute of Experimental Medicine (IEM), shares her insights on the institute’s involvement in research and with the private sector, the key strengths of…
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
Oliver Strommer, newly appointed executive director of the British Chamber of Commerce in Hungary (BCCH), introduces the Chamber and its refocused aim of becoming a more dynamic player in business…
Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort between the public and private sectors…
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European market with more affordable biologic medicines and bolstering Hungary’s footprint in…
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most affected areas and oncology patients are now also…
Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria and Slovakia.leading some organisations to urge the government to increase…
Hungary’s Minister of Finance Mihály Varga has repeatedly underlined the importance of the pharmaceutical industry to the country’s economy in recent weeks. With this strong governmental backing, pharma stands to…
Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in…
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country’s innovative pharma association has taken the initiative to suggest measures that…
See our Cookie Privacy Policy Here